CLIMB BIO, INC. (CLYM) Operating income 2020–2025
CLIMB BIO, INC. (CLYM) annual operating income history from SEC filings — each fiscal year as reported.
-$67.9MFY2025 · since FY2020: -$20.9M → -$67.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$67.9M | +17.2% |
| FY2024 | -$82.0M | -103.6% |
| FY2023 | -$40.3M | +10.8% |
| FY2022 | -$45.1M | -26.5% |
| FY2021 | -$35.7M | -70.5% |
| FY2020 | -$20.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLYM financial trends
CLYM RevenueCLYM Net incomeCLYM Net marginCLYM Gross profitCLYM Gross marginCLYM Operating marginCLYM Operating cash flowCLYM Free cash flowCLYM Capital expendituresCLYM Return on equityCLYM Stock buybacksCLYM Dividends paidCLYM Total assetsCLYM Total liabilitiesCLYM Shareholders’ equityCLYM overview →